clinical trials
Clinical research trials are studies conducted to test new and innovative treatments, medications, or medical interventions to determine their safety and effectiveness. During these sponsored studies, researchers carefully design a plan, called a protocol, which outlines how the study will be conducted and provides very close monitoring of results throughout the entire study. The primary goal of these trials is to evaluate how effective the studied treatment is, to determine any side effects and to promote new and alternative treatments. It's a collaborative effort between researchers, volunteers, and local healthcare professionals, all working towards advancing medicine and improving individual health outcomes.
Be part of the solution
By signing up for a clinical trial you’re taking a proactive role in your own healthcare, gaining access to new treatments, and contributing to the advancement of healthcare science. The process is simple – fill out an application for any current clinical research studies you feel you may be eligible for and one of our team members will contact you and guide you through the rest of the process.
-
Gain access to new research treatments before they are available to the general public.
-
Play an active role in your own healthcare while also helping others.
-
Save medical costs by participating in trials – no insurance is needed!
BENEFITS of participating in research studies include:
Compensation for time & travel paid at visit
No cost study-related exams and treatment
Access to new treatments before they are available to the public
Quality care focusing on your medical condition(s)
New treatment alternatives when standard treatments may be insufficient
phase 01.
I studies are the first in a series of clinical trials in which a new drug or treatment is tested on a human subject. These tests help researchers determine the best dosing, timing and administration for a new treatment and also provide insights into how the drug reacts with the body. There are many types of studies that are conducted at our clinics. Sometimes, a study is a combination of multiple study types
phase 02.
The Phase II of a clinical trial lets doctors know how safe a treatment is and how well it works. They will also be able to tell if the specific treatment fits your needs in treating your disease while closely monitoring safety and side effects.
phase 03.
Phase III of a clinical trial will test the safety and ability of a new treatment compared to standard therapy. This is achieved by closely monitoring, collecting, and comparing data from study groups.
phase 04.
Phase IV of a clinical trial continues to monitor and collect data of a new treatment over a longer period of time after it has been FDA approved. Long-term use and interaction with other treatments will continue to be
Currently enrolling Clinical Studies
Simply fill out an application for any current clinical research studies you feel you may be eligible for and one of our team members will contact you and guide you through the rest of the process.
-
WHO IS ELIGIBLE: Cytomegalovirus Vaccine for healthy females ages 16 - 18
EXPECTED STUDY DURATION: 2 to 3 years
-
WHO IS ELIGIBLE: Ages 6 - 17 with Irritable bowel syndrome with constipation (IBS-C), abdominal discomfort or pain.
-
Treatment and relief of symptoms associated with diabetic gastroparesis. Gastroparesis is a condition where the stomach does not empty properly. In a healthy stomach, the muscles push food through the digestive system. Gastroparesis is when the stomach muscles fail to empty the stomach normally and can be common amongst those with Diabetes Mellitus.
WHO IS ELIGIBLE: Male or Female >/= 18 years of age currenlty diagnosed with diabetic gastroparesis.
EXPECTED STUDY DURATION: A total of (9) study visits over a period of approximately 56 weeks.
-
A study to understand and identify cancer biomarkers in a blood sample, which will be combined with general medical record information including demographics and medical history as well as cancer screening outcomes. This information will be used to further develop and evaluate content, methodology, specimen processing and quality control for test application in cancer screening.
WHO IS ELIGIBLE: Male & Females: Ages 45-84
EXPECTED STUDY DURATION: One Visit, includes a scheduled blood draw prior to your upcoming prep for colonoscopy
*Must be scheduled for your FIRST and upcoming screening colonoscopy*
-
A study to evaluate the effectiveness of a once daily treatment for premenopausal women ages 18-49 with endometriosis and associated pain.
WHO IS ELIGIBLE: Premenopausal females 18 to 49 years of age, with documented diagnosis of Endometriosis and experiencing moderate to severe pain
EXPECTED STUDY DURATION: Approximately 18 months, must be able to attend 5 study visits in the 1st 3 months and then once every 3 months.
-
Details coming soon!
-
A study to evaluate the effectiveness of a once daily treatment in female subjects with Interstitial Cystitis and / or Bladder Pain Syndrome.
WHO IS ELIGIBLE: Females 18 - 64 years of age, diagnosed with interstitial cystitis or bladder pain syndrome
EXPECTED STUDY DURATION: 9 study visits within a 4 month period
-
A study for pediatrics and adults with minor soft tissue injury within the last 96 hours
WHO IS ELIGIBLE: Ages 6-11, 12-16, and 18 - 45 years old
EXPECTED STUDY DURATION: Requires 3 study visits
-
A Phase III study to investigate the safety, tolerability, and efficacy of once daily treatment in participants with inadequately controlled severe eosinophilic asthma.
WHO IS ELIGIBLE: Male or female ≥12 years of age with uncontrolled and moderate to severe asthma
EXPECTED STUDY DURATION: 1 year
-
Details coming soon!
-
Details coming soon!
-
Details coming soon!